Close Menu

NEW YORK (360Dx) – Israeli in vitro diagnostics firm Todos Medical today announced a distribution deal with Orot+ for Todos' TM-B2 blood tests for breast cancer screening in Romania and Austria.

Orto+, headquartered in Tel Aviv, Israel will be responsible for the costs of marketing and distributing TM-B2. Todos will use data from the commercialization efforts to support further development and commercialization of the test in other geographies, it said. Additional terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.